JP2022501412A5 - - Google Patents

Info

Publication number
JP2022501412A5
JP2022501412A5 JP2021517993A JP2021517993A JP2022501412A5 JP 2022501412 A5 JP2022501412 A5 JP 2022501412A5 JP 2021517993 A JP2021517993 A JP 2021517993A JP 2021517993 A JP2021517993 A JP 2021517993A JP 2022501412 A5 JP2022501412 A5 JP 2022501412A5
Authority
JP
Japan
Prior art keywords
compound according
linear
alkylene
section
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021517993A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022501412A (ja
JP7485659B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/054240 external-priority patent/WO2020072605A1/en
Publication of JP2022501412A publication Critical patent/JP2022501412A/ja
Publication of JP2022501412A5 publication Critical patent/JP2022501412A5/ja
Priority to JP2024074775A priority Critical patent/JP2024102224A/ja
Application granted granted Critical
Publication of JP7485659B2 publication Critical patent/JP7485659B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021517993A 2018-10-02 2019-10-02 イオン化可能なアミン脂質 Active JP7485659B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024074775A JP2024102224A (ja) 2018-10-02 2024-05-02 イオン化可能なアミン脂質

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862740274P 2018-10-02 2018-10-02
US62/740,274 2018-10-02
PCT/US2019/054240 WO2020072605A1 (en) 2018-10-02 2019-10-02 Ionizable amine lipids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024074775A Division JP2024102224A (ja) 2018-10-02 2024-05-02 イオン化可能なアミン脂質

Publications (3)

Publication Number Publication Date
JP2022501412A JP2022501412A (ja) 2022-01-06
JP2022501412A5 true JP2022501412A5 (cg-RX-API-DMAC7.html) 2022-10-07
JP7485659B2 JP7485659B2 (ja) 2024-05-16

Family

ID=68425250

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021517993A Active JP7485659B2 (ja) 2018-10-02 2019-10-02 イオン化可能なアミン脂質
JP2024074775A Withdrawn JP2024102224A (ja) 2018-10-02 2024-05-02 イオン化可能なアミン脂質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024074775A Withdrawn JP2024102224A (ja) 2018-10-02 2024-05-02 イオン化可能なアミン脂質

Country Status (17)

Country Link
US (2) US20220009878A1 (cg-RX-API-DMAC7.html)
EP (1) EP3860972A1 (cg-RX-API-DMAC7.html)
JP (2) JP7485659B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210093871A (cg-RX-API-DMAC7.html)
CN (1) CN113039174B (cg-RX-API-DMAC7.html)
AU (1) AU2019351917B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021006270A2 (cg-RX-API-DMAC7.html)
CA (1) CA3114032A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021005774A2 (cg-RX-API-DMAC7.html)
EA (1) EA202190916A1 (cg-RX-API-DMAC7.html)
IL (2) IL281948B2 (cg-RX-API-DMAC7.html)
MX (1) MX2021003455A (cg-RX-API-DMAC7.html)
PH (1) PH12021550701A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202102921WA (cg-RX-API-DMAC7.html)
TW (1) TW202028170A (cg-RX-API-DMAC7.html)
UA (1) UA128190C2 (cg-RX-API-DMAC7.html)
WO (1) WO2020072605A1 (cg-RX-API-DMAC7.html)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021003726A (es) 2018-10-01 2021-05-13 BioNTech SE Particulas de arn que comprenden polisarcosina.
WO2020219876A1 (en) * 2019-04-25 2020-10-29 Intellia Therapeutics, Inc. Ionizable amine lipids and lipid nanoparticles
JP7600208B2 (ja) 2019-07-29 2024-12-16 ジョージア テック リサーチ コーポレイション 拘束された脂質を含むナノ材料およびその使用
US12521451B2 (en) 2019-11-08 2026-01-13 Regeneron Pharmaceuticals, Inc. CRISPR and AAV strategies for x-linked juvenile retinoschisis therapy
CN115175894B (zh) 2020-01-09 2024-09-06 盖德治疗有限责任公司 纳米材料
CN118490818A (zh) 2020-04-22 2024-08-16 生物技术欧洲股份公司 冠状病毒疫苗
KR20230017783A (ko) 2020-04-28 2023-02-06 인텔리아 테라퓨틱스, 인크. 시험관내 세포 전달 방법
MX2023004371A (es) 2020-10-14 2023-07-26 George Mason Res Foundation Inc Lípidos ionizables, y métodos de fabricación y uso de los mismos.
WO2022101471A1 (en) * 2020-11-16 2022-05-19 BioNTech SE Pharmaceutical compositions comprising lipid nanoparticles and mrna, and methods for preparing and storing the same
TW202237148A (zh) * 2020-11-16 2022-10-01 德商拜恩迪克公司 包含rna之lnp組合物以及製備、儲存及使用彼之方法
US20240041785A1 (en) * 2020-11-16 2024-02-08 BioNTech SE Compositions and methods for stabilization of lipid nanoparticle mrna vaccines
CN116782889A (zh) * 2020-11-16 2023-09-19 生物技术欧洲股份公司 增强的制剂稳定性和改善的冻干工艺
WO2022218503A1 (en) * 2021-04-12 2022-10-20 BioNTech SE Lnp compositions comprising rna and methods for preparing, storing and using the same
CN117042758A (zh) * 2020-11-16 2023-11-10 生物技术欧洲股份公司 用于稳定化脂质纳米颗粒mRNA疫苗的组合物和方法
EP4259792A1 (en) 2020-12-11 2023-10-18 Intellia Therapeutics, Inc. Polynucleotides, compositions, and methods for genome editing involving deamination
JP2024505327A (ja) * 2020-12-21 2024-02-06 ビーム セラピューティクス インク. 炭酸塩を含むナノ材料
CN116887841A (zh) * 2020-12-21 2023-10-13 比姆医疗股份有限公司 包括酯连接缩醛的纳米材料
JP2024508347A (ja) * 2020-12-21 2024-02-27 ビーム セラピューティクス インク. エステル結合アセタールを含むナノ材料
EP4262817A4 (en) * 2020-12-21 2025-03-12 Beam Therapeutics Inc. NANOMATERIALS WITH ACETALS
CN116761888A (zh) 2021-01-20 2023-09-15 比姆医疗股份有限公司 纳米材料
EP4281080A4 (en) * 2021-01-20 2025-09-24 Beam Therapeutics Inc NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT
CN112961065B (zh) * 2021-02-05 2023-03-14 嘉晨西海(杭州)生物技术有限公司 一种可电离脂质分子及其制备方法及其在制备脂质纳米颗粒的应用
CN115197079A (zh) 2021-04-08 2022-10-18 厦门赛诺邦格生物科技股份有限公司 一种聚乙二醇化脂质及其修饰的脂质体、含该脂质体的药物组合物及其制剂和应用
CN117327270B (zh) * 2021-04-08 2026-07-07 厦门赛诺邦格生物科技股份有限公司 一种聚乙二醇化脂质及其修饰的脂质体、含该脂质体的药物组合物及其制剂和应用
US20240300977A1 (en) 2021-04-17 2024-09-12 Intellia Therapeutics, Inc. Inhibitors of dna-dependent protein kinase and compositions and uses thereof
CA3216873A1 (en) 2021-04-17 2022-10-22 Intellia Therapeutics, Inc. Lipid nanoparticle compositions
WO2022251665A1 (en) * 2021-05-28 2022-12-01 Renagade Therapeutics Management Inc. Lipid nanoparticles and methods of use thereof
TW202317764A (zh) 2021-06-10 2023-05-01 美商英特利亞醫療公司 用於基因編輯之包含內部連接子之經修飾引導rna
WO2022271780A1 (en) * 2021-06-22 2022-12-29 Intellia Therapeutics, Inc. Methods for in vivo editing of a liver gene
TW202328067A (zh) 2021-09-14 2023-07-16 美商雷納嘉德醫療管理公司 環狀脂質及其使用方法
WO2023044343A1 (en) * 2021-09-14 2023-03-23 Renagade Therapeutics Management Inc. Acyclic lipids and methods of use thereof
KR20240090727A (ko) 2021-10-22 2024-06-21 세일 바이오메디슨스, 인크. Mrna 백신 조성물
EP4426271B1 (en) * 2021-11-02 2025-07-23 Ziphius Nv Lipid nanoparticles for oligonucleotide delivery
EP4426822A2 (en) 2021-11-03 2024-09-11 Intellia Therapeutics, Inc. Polynucleotides, compositions, and methods for genome editing
US20250002941A1 (en) 2021-11-23 2025-01-02 Sail Biomedicines, Inc. A bacteria-derived lipid composition and use thereof
US12186387B2 (en) 2021-11-29 2025-01-07 BioNTech SE Coronavirus vaccine
EP4452239A1 (en) 2021-12-20 2024-10-30 Sail Biomedicines, Inc. Compositions comprising mrna and lipid reconstructed plant messenger packs
WO2023138611A1 (en) * 2022-01-19 2023-07-27 Suzhou Abogen Biosciences Co., Ltd. Lipid compounds and lipid nanoparticle compositions
CN114874104B (zh) * 2022-04-29 2024-11-29 湖北英纳氏生物科技有限公司 阳离子脂质体SM-102及Lipid5的制备方法
WO2023222081A1 (zh) 2022-05-19 2023-11-23 仁景(苏州)生物科技有限公司 长链烷基酯胺类脂质化合物及其制备方法和在核酸递送方面的应用
CN119384498A (zh) 2022-06-16 2025-01-28 因特利亚治疗公司 用于对细胞进行遗传修饰的方法和组合物
US11878055B1 (en) 2022-06-26 2024-01-23 BioNTech SE Coronavirus vaccine
EP4540222A1 (en) 2022-07-20 2025-04-23 Beam Therapeutics Inc. Nanomaterials comprising triols
WO2024078614A1 (zh) * 2022-10-13 2024-04-18 深圳深信生物科技有限公司 用于递送生物活性成分的氨基脂质化合物和脂质纳米颗粒
EP4615424A1 (en) 2022-11-10 2025-09-17 Sail Biomedicines, Inc. Rna compositions comprising lipid nanoparticles or lipid reconstructed natural messenger packs
WO2024117978A1 (en) * 2022-11-30 2024-06-06 Agency For Science, Technology And Research (A*Star) Methods of synthesising ionisable lipids
EP4638783A2 (en) 2022-12-22 2025-10-29 Intellia Therapeutics, Inc. Methods for analyzing nucleic acid cargos of lipid nucleic acid assemblies
CN120418427A (zh) 2022-12-23 2025-08-01 因特利亚治疗公司 用于基因组编辑的系统和方法
JP2026503676A (ja) 2023-01-27 2026-01-29 セイル バイオメディシンズ インコーポレイテッド 修飾脂質組成物およびその使用
WO2024220712A2 (en) 2023-04-19 2024-10-24 Sail Biomedicines, Inc. Vaccine compositions
EP4698150A1 (en) 2023-04-19 2026-02-25 Sail Biomedicines, Inc. Delivery of polynucleotides from lipid nanoparticles comprising rna and ionizable lipids
WO2024220752A2 (en) 2023-04-19 2024-10-24 Sail Biomedicines, Inc. Rna therapeutic compositions
TW202511244A (zh) * 2023-04-28 2025-03-16 日商日東電工股份有限公司 脂質及包含其之醫藥組合物、以及傳遞活性醫藥成分之方法
AU2024312860A1 (en) * 2023-06-21 2026-01-22 Renagade Therapeutics Management Inc. Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
WO2025000542A1 (en) * 2023-06-30 2025-01-02 Shanghai Vitalgen Biopharma Co., Ltd. Ionizable cationic lipid compounds for delivery of biologically active agents
WO2025049481A1 (en) 2023-08-28 2025-03-06 Intellia Therapeutics, Inc. Methods of editing an hla-a gene in vitro
EP4780984A1 (en) 2023-09-18 2026-07-29 Intellia Therapeutics, Inc. Nuclease resistant single stranded dna product for non-viral delivery to a cell and methods of production thereof
EP4780983A1 (en) 2023-09-18 2026-07-29 Intellia Therapeutics, Inc. Nuclease resistant double stranded dna product for non-viral delivery to a cell and methods of production thereof
WO2025106915A1 (en) 2023-11-17 2025-05-22 Sail Biomedicines, Inc. Circular polyribonucleotides encoding glucagon-like peptide 1 (glp-1) and uses thereof
WO2025106930A1 (en) 2023-11-17 2025-05-22 Sail Biomedicines, Inc. Circular polyribonucleotides encoding glucagon-like peptide 2 (glp-2) and uses thereof
WO2025128871A2 (en) 2023-12-13 2025-06-19 Renagade Therapeutics Management Inc. Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
WO2025137301A1 (en) 2023-12-20 2025-06-26 Intellia Therapeutics, Inc. Methods for rapid engineering of cells
CN118255678B (zh) * 2024-03-28 2024-12-24 荣灿生物医药技术(上海)有限公司 一种可电离脂质化合物及其应用
WO2025240946A1 (en) 2024-05-17 2025-11-20 Intellia Therapeutics, Inc. Lipid nanoparticles and lipid nanoparticle compositions
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles
WO2026035680A1 (en) 2024-08-06 2026-02-12 Kernal Biologics, Inc. Compositions and methods for delivery of agents
WO2026097018A1 (en) 2024-11-04 2026-05-07 Intellia Therapeutics, Inc. Polypeptides, polynucleotides, compositions, and methods for genome editing involving chromatin remodelers
WO2026163162A1 (en) 2025-01-31 2026-08-06 Intellia Therapeutics, Inc. Enhanced cas9 variants and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1021549A2 (en) 1997-09-19 2000-07-26 Sequitur, Inc. SENSE mRNA THERAPY
WO2006007712A1 (en) 2004-07-19 2006-01-26 Protiva Biotherapeutics, Inc. Methods comprising polyethylene glycol-lipid conjugates for delivery of therapeutic agents
US20100055169A1 (en) * 2008-04-16 2010-03-04 Abbott Laboratories Cationic lipids and uses thereof
WO2011076807A2 (en) 2009-12-23 2011-06-30 Novartis Ag Lipids, lipid compositions, and methods of using them
DE21212055T1 (de) * 2011-12-07 2022-08-04 Alnylam Pharmaceuticals, Inc. Biologisch abbaubare lipide zur freisetzung von wirkstoffen
ES2887254T3 (es) 2013-03-08 2021-12-22 Novartis Ag Lípidos y composiciones lipídicas para el suministro de agentes activos
US10059655B2 (en) 2013-12-19 2018-08-28 Novartis Ag Lipids and lipid compositions for the delivery of active agents
CN106794141B (zh) 2014-07-16 2021-05-28 诺华股份有限公司 将核酸包封在脂质纳米粒主体中的方法
HRP20220156T1 (hr) 2015-09-17 2022-04-15 Modernatx, Inc. Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
CN108368028B (zh) * 2015-10-28 2021-09-03 爱康泰生治疗公司 用于递送核酸的新型脂质和脂质纳米颗粒制剂
RS63953B1 (sr) * 2017-03-15 2023-02-28 Modernatx Inc Jedinjenje i kompozicije za intracelularnu isporuku terapeutskih sredstava

Similar Documents

Publication Publication Date Title
JP2022530043A5 (cg-RX-API-DMAC7.html)
JP2022514214A5 (cg-RX-API-DMAC7.html)
IL317488A (en) Ionizable lipid amines
JP6758335B2 (ja) テロメラーゼ阻害のための改変オリゴヌクレオチド
US20220280542A1 (en) Phosphoramidates for the treatment of hepatitis b virus
US9861589B2 (en) Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery
CA2100269C (en) Use of 1, 3-oxathiolane nucleoside analogues in the treatment of hepatitis b
JP2024515650A5 (cg-RX-API-DMAC7.html)
JP3179494B2 (ja) プロブコールの可溶性類似体
EP1094815B1 (en) Farnesyl protein transferase inhibitors for treating arthropathies
CA2895866C (en) Oligonucleotide analogues incorporating 5-aza-cytosine therein
US7709449B2 (en) Nucleic acid-based compounds and methods of use thereof
ES2537568T3 (es) Nuevos fármacos para inhibición de la expresión genética
US12629421B2 (en) Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid
CN1424913A (zh) 抗病毒前体药物
JP2023513698A5 (cg-RX-API-DMAC7.html)
TWI924663B (zh) 用於抑制PNPLA3表現之RNAi劑、其醫藥組成物及使用方法
US11974969B2 (en) Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid
IL294599A (en) 4’-o-methylene phosphonate nucleic acids and analogues thereof
WO2021110148A1 (zh) siRNA缀合物、双链siRNA缀合物及其盐和应用
CN117897152A (zh) 含有糖官能化核酸载体的纳米颗粒组合物
KR940010441B1 (ko) B형감염의 항비루스제
US20230144739A1 (en) Treatment of covid-19 with reverse micelle system comprising unmodified oligonucleotides
JPH04501854A (ja) 肝炎の治療方法
JP2021155397A (ja) ベータコロナウイルス感染を防止する組成物